Do More With Reuters
Partner Services

Ranbaxy drug buy a sign India predators may now be prey

Fri Jun 13, 2008 9:32am IST
 
Email | Print | | Single Page
[-] Text [+]

By Hiral Vora and Bharghavi Nagaraju

MUMBAI (Reuters) - Daiichi Sankyo's $4.6 billion bid for control of India's Ranbaxy Laboratories Ltd could be the trigger for foreign pharmaceutical companies to step up the hunt for low-cost Indian drug makers for fear of being left behind.

Global demand for cheaper generic medicines produced by firms such as Ranbaxy is booming as countries battle rising healthcare costs. Diversifying into the business would boost revenues for bigger firms, helping them to offset the growing cost of developing new drugs and fend off rivals.

Indian drug makers, who until recently were on an acquisition spree of their own, are now seen as attractive targets by foreign firms seeking entry to the fast-growing market, their research and development expertise and a low-cost manufacturing base.

Ranbaxy's larger, family-controlled rivals such as Cipla Ltd, Dr Reddy's Laboratories Ltd and mid-sized Aurobindo Pharma could be potential targets.

"Cipla has been a target for some time," said an investment banker, who asked not to be identified for commercial reasons.

"The promoter holding in Dr. Reddy's is quite low," the banker said, referring to the founder or controlling family stake.

Unlike sectors such as telecoms and banking, India does not cap foreign investment in pharmaceuticals firms, removing another potential hurdle for foreign takeovers.

The Indian pharmaceutical market is dominated by small- and medium-sized family-run firms which prefer to function independently, making a mix of generics -- cheaper off-patent drugs -- as well are more common medicines and health products such as aspirins and vitamins.  Continued...

India Investment Summit 2009
India Investment Summit 2009

Top executives and bankers discuss their own plans and the broader opportunities and challenges for India.  Full Coverage 

GLOBAL RECOVERY

A labourer works on a flyover bridge at a construction site in New Delhi October 14, 2009. REUTERS/Parth Sanyal/Files
Global economy in holding pattern - IMF

The global economy is in a holding pattern and vulnerable to more upheaval, the head of the IMF said, adding a lasting recovery will depend on policymakers taking the proper steps in the coming months.  Full Article 

Photo
A man walks past a bronze statue of a bull outside the Bombay Stock Exchange (BSE) building in Mumbai in this March 25, 2008 file photo. REUTERS/Punit Paranjpe/Files
Bubble trouble?

With India's benchmark stock index, the BSE Sensex, at around 17,000 points, are the Indian equity markets looking at a possible bubble?  Commentary 

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

BLOGS

Photo
Calculated Move

Reliance aims big with $12 bln bid for LyondellBasell.  Blog 

showcase

U.S. Recession
U.S. Recession

A trip through the epicenters of the American recession.  Full Coverage 

 
Central Banks Cautious
Central Banks Cautious

Reuters tracks the policies of the world's top central banks as the debate over global economic recovery rages on.   Full Coverage 

 
T P Raman
Column - RBI leads the world

Reserve Bank of India's approach ring-fenced the banking system.   Full Article 

 
Funding Blues
Funding Blues

A popular tactic used by Indian brokerages to raise money for rich clients is likely to be banned.  Full Article 

 
Not Enough Jobs
Not Enough Jobs

Venture capital creates jobs, but not enough.  Full Article 

 
Column - A Sweet Dream
Column - A Sweet Dream

There are good reasons for Ferrero to consider a combination with Cadbury.  Full Article